Nykredit A/S’s Edwards Lifesciences EW Stock Holding History

Nykredit A/S’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.2M	Buy	+212,551	New	+$17.8M	0.07%	223

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Nykredit A/S's EW Position: Q2 2026 in Review

Nykredit A/S opened a new position in Edwards Lifesciences (EW) in Q2 2026: 212,551 shares worth $19.2M. The stake represents 0.07% of the portfolio and ranks #223 among its holdings.

1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Nykredit A/S held 212,551 shares of Edwards Lifesciences worth $19.2M as of Q2 2026.
Edwards Lifesciences was a new Nykredit A/S position in Q2 2026.
Edwards Lifesciences made up 0.07% of Nykredit A/S's portfolio in Q2 2026, its #223 holding.
1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.